CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1800.50-24.5 (-1.34 %)
PREV CLOSE () 1825.00
OPEN PRICE () 1797.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20836
TODAY'S LOW / HIGH ()1796.30 1833.50
52 WK LOW / HIGH ()1547.25 1850.95
NSE1801.60-23.7 (-1.3 %)
PREV CLOSE() 1825.30
OPEN PRICE () 1822.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1801.60 (797)
VOLUME 2554627
TODAY'S LOW / HIGH() 1797.00 1833.30
52 WK LOW / HIGH ()1548 1851.2
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

Dilip S Shanghvi - Chairman Kirti Ganorkar - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja, ,
Vadodara,
Gujarat-390012

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
01Feb Sun Pharma reports 16% rise in Q3 cons
Sun Pharmaceutical Industries has reported results for third quarter end..
01Feb Sun Pharma gains on reporting 16% rise
Sun Pharmaceutical Industries is currently trading at Rs. 1613.00, up by..
01Feb Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that the Company has publishe..
23Jan Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that it enclosed a copy of th..
23Jan Sun Pharma gets DCGI’s nod to manufact
Sun Pharmaceutical Industries has secured approval from the Drugs Contro..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit7054.4000000000142826.2
Gross Profit 10971 50305.7
Operating Profit 1938571620.5
Net Sales 56877.7230033.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26916.10 (0.83%)
M.Cap ( in Cr)
57194.83
BDH Inds (BSE)
 402.35 (9.92%)
M.Cap ( in Cr)
231.64
Onesource Specialty (BSE)
 1488.70 (1.43%)
M.Cap ( in Cr)
17063.66
Mercury Laboratories (BSE)
 800.00 (2.56%)
M.Cap ( in Cr)
96.00
Strides Pharma Scien (BSE)
 922.25 (1.19%)
M.Cap ( in Cr)
8500.63
Shareholding Pattern
PROMOTERS 54.48%
MUTUAL FUNDS/UTI 12.09%
NON-INSTITUTION 8.58%
FI/BANKS/INSURANCE 6.66%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74563.92-1470.50 (-1.93%)
NIFTY23151.10-488.05 (-2.06%)
Dow Jones 46558.47-119.38 (-0.26%)
Nasdaq 22105.36-206.62 (-0.93%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI